KIM RUNSER: Open Payments
NPI 1770003964 · VAN WERT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 34 payments from 13 companies in 2025. Trend: 2023 $772 · 2024 $1,062 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| ABBVIE INC. | 5 | $91 |
| Novo Nordisk Inc | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Abbott Laboratories | 2 | $50 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: REXULTI, FREESTYLE LIBRE 3, ZENPEP, Ozempic, AIRSUPRA, ARISTADA, QULIPTA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
